These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28926900)

  • 1. [The combination of percutaneous iohexol-ethanol injection with radiofrequency ablation for the treatment of primary liver cancer in high-risk locations].
    Sun W; Ding XY; Chen JL; Li WD; Wang XY; Guo XD; Shen YJ; Sun SS
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):695-700. PubMed ID: 28926900
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
    Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
    Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
    BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P; Zhang Z; Kuai J
    J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
    Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J
    Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
    AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
    Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.
    Wang WD; Zhang LH; Ni JY; Jiang XY; Chen D; Chen YT; Sun HL; Luo JH; Xu LF
    Korean J Radiol; 2018; 19(4):613-622. PubMed ID: 29962868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
    Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of (125)I radioactive seed implantation plus transcatheter arterial chemoembolization combined with radiofrequency ablation in treating patient with sub-capsular hepatocellular carcinoma].
    Fang SJ; Gao RJ; Zheng LY; Zhao ZW; Fan XX; Song JJ; Zhang DK; Wu FZ; Ji JS
    Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3853-3857. PubMed ID: 30585029
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical efficiency of TACE combined with simultaneous computed tomography-guided radiofrequency ablation for advanced hepatocellular carcinoma.
    Yuan P; Wang F; Zhu G; Chen B
    Invest New Drugs; 2021 Oct; 39(5):1383-1388. PubMed ID: 33754235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.
    Hocquelet A; Seror O; Blanc JF; Frulio N; Salut C; Nault JC; Trillaud H
    Oncotarget; 2017 May; 8(19):32190-32200. PubMed ID: 27793027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of chemoembolization with simultaneous radiofrequency ablation for treatment of adrenal metastases from hepatocellular carcinoma.
    Yuan H; Liu F; Li X; Guan Y; Wang M
    Cancer Imaging; 2018 Jul; 18(1):24. PubMed ID: 30064514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
    Morimoto M; Numata K; Kondou M; Nozaki A; Morita S; Tanaka K
    Cancer; 2010 Dec; 116(23):5452-60. PubMed ID: 20672352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.